Sotera Health SHC Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 55.5%+0.7pp | 54.7%-0.3pp | 55%-0.5pp | 55.5%-0.2pp | |
| Net margin | 6.7%+2.7pp | 4%-0.9pp | 4.9%+28.2pp | -23.3%-35.8pp | |
| Returns | |||||
| Return on equity | 15.4%+5.0pp | 10.5%-2.5pp | 12.9%+62.8pp | -49.9%-72.4pp | |
| Return on invested capital | -0.2%-6.2pp | 6%-0.2pp | 6.2%-5.4pp | 11.6%+4.1pp | |
| Efficiency | |||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | |||||
| Current ratio | 2.5×-0.3× | 2.8×+0.3× | 2.4×+1.6× | 0.8×-1.3× | |
| Leverage | |||||
| Debt-to-equity | 3.8×-2.1× | 5.8×+0.6× | 5.2×-0.6× | 5.8×+2.7× | |
| Net debt / EBITDA | 15×+10.5× | 4.5×-0.2× | 4.7×+0.5× | 4.2×-0.1× | |
| Per Share | |||||
| Book value per share | $2.12+48.9% | $1.42-9.3% | $1.57+25.3% | $1.25-40.4% | |
| Valuation | |||||
| Market capitalization | $5.01B+29.3% | $3.87B-18.3% | $4.74B+103% | $2.34B-64.6% | |
| Price / earnings | 64.3×-23.0× | 87.3×-5.0× | 92.3×— | —— | |
| Price / sales | 4.3×+0.8× | 3.5×-1.0× | 4.5×+2.2× | 2.3×-4.7× | |
| Price / book | 8.3×-1.3× | 9.6×-1.1× | 10.7×+4.0× | 6.7×-4.6× | |
| EV / EBITDA | 54×+41.1× | 12.9×-2.7× | 15.6×+5.5× | 10.1×-10.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sotera Health's profit margins?
- Sotera Health (SHC) runs a 55.3% gross margin and a 27.0% operating margin, with a 9.9% net margin.
- Where do Sotera Health's ratios come from?
- Every ratio is computed from Sotera Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.